Men with localised prostate cancer often are treated with external radiotherapy (RT) over 8 to 9 weeks. Hypofractionated RT is given over a shorter time with larger doses per treatment than standard RT. These researchers hypothesised that hypofractionation versus conventional fractionation is similar in efficacy without increased toxicity.